Monarch Medical Technologies

Monarch Medical Technologies is a healthcare technology company specializing in patient-specific insulin dosing and inpatient glycemic management solutions tailored for hospital settings. Since 2003, the company has focused on improving glucose control and patient safety by replacing traditional paper-based protocols with its FDA-cleared EndoTool® Glucose Management System, which uses adaptive, patient-specific algorithms to guide precise insulin dosing for both intravenous and subcutaneous therapy. By continuously integrating real-time clinical data and predictors like renal function and residual insulin, the platform helps clinicians reduce variability, minimize severe hypoglycemia, and enhance workflow efficiency across critical and non-critical care units. Trusted by major health systems and backed by clinical evidence, Monarch’s solutions deliver alerts, insights, and analytics that support safer, more effective glycemic management in complex care environments.